Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on April 28, 2016, to announce its financial results for the first quarter ended March 31, 2016. The report primarily references a press release (Exhibit 99.1) containing these results, which were presented on both a GAAP and non-GAAP basis. Management believes the non-GAAP presentation offers additional insight for investors, aiding in the understanding of operating performance and financial planning, though it should be considered supplementary to the official GAAP figures. A detailed reconciliation between GAAP and non-GAAP measures is available within the press release. Investors should refer to the press release filed as Exhibit 99.1 for the specific financial figures and management's commentary on the quarter's performance. The 8-K itself serves as a notification of the earnings release and does not contain the detailed financial statements but directs stakeholders to the accompanying exhibit for comprehensive information. The company emphasizes that the information presented is not considered "filed" for certain regulatory purposes.
Key Highlights
- 1Gilead Sciences announced its Q1 2016 financial results on April 28, 2016, via an 8-K filing.
- 2The financial results were disclosed in an accompanying press release (Exhibit 99.1).
- 3Both GAAP and non-GAAP financial measures were presented for the quarter ended March 31, 2016.
- 4Management believes non-GAAP financial information is useful for investors and for internal operational and financial planning.
- 5A reconciliation between GAAP and non-GAAP financial information is provided in the press release.
- 6The information furnished in the 8-K and exhibit is not deemed 'filed' for purposes of Section 18 of the Exchange Act.